Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14607)	9/16/2000 4:03:58 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Cacaito, first.....CALM DOWN!!! Haven't you more than made up your losses by your investment in ICOS??? You know in your heart that Neuprex as at least an antibacterial and an antibiotic helper would do wonders for kids with Meningococcemia if given early. Let us ALL join together and do something for kids that get Meningococcemia. Yelling that Neuprex was a failure is not right. Reduction in amputations alone would be more than enough to get this approved under subpart E. You would be proud and could even tell all your grandkids how you helped bring this miracle medication to kids with meningococcemia. Stand up and be counted with Dr. Girior and others. IT IS THE RIGHT THING TO DO.